GBGeorge M. Bou-Assaf

George M. Bou-Assaf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


George M. Bou-Assaf has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chemical cleavage coupled with LCMS to report on the true diastereomeric distributions of phosphorothioate linkages in gapmer ASO

    by Zifan Li, Tai Nguyen, Xuan Zhou, Li Xiao, George M. Bou-Assaf

    Phosphorothioate (PS) modifications are commonly employed to enhance the performance of antisense oligonucleotides (ASOs). Each phosphorus atom at a PS linkage acts as a chiral center, typically resulting in thousands or more diastereomers in a therapeutic PS ASO. Since the synthesis of most PS ASOs under development is not stereo-selective, establishing stereochemical comparability between batches is crucial for ensuring the consistency of the drug substance. In this study, we evaluate a nuclease-free approach based on the Maxam-Gilbert sequencing and alkylation sequencing method to chemically cleave gapmer PS ASOs into smaller fragments to facilitate the chromatographic separation of diastereomers. Compared to our previous report using nuclease P1 coupled with liquid chromatography-mass spectrometry analysis, the chemical cleavage approach demonstrated superior repeatability and sensitivity in analyzing gapmer PS ASOs. Beyond comparability, this method can accurately report on the true diastereomeric distributions at certain PS linkages, which significantly benefits the comparison of stereochemistry pre- and post-purification. Graphical Abstract


  • Differentiation of n-1 Positional Isomers in Antisense Oligonucleotides with Orthogonal LCMS Methods

    by Zifan Li, Xiaoqing Kong, Xiao Zhou, Li Xiao, Rasika Phansalkar, Tai Nguyen, Thomas C. Pickel, David Cho, Xuan Zhou, George M. Bou-Assaf

    Investigating the origin of critical product-related impurities during solid-phase synthesis is essential to improving the quality of therapeutic oligonucleotides. In the synthesis of a 2'-O-[2-(methylamino)-2-oxoethyl] modified phosphorothioate antisense oligonucleotide (NMA PS ASO), we observed elevated levels of n minus NMA 5-methylcytosine (n-NMA MeC), where n is the full-length product (FLP). This impurity, which results from the deletion of any of the five NMA MeC residues in the oligonucleotide sequence, is the major contributor to the n-1 class of impurities. High-resolution mass spectrometry cannot differentiate positional isomers arising from specific nucleotide deletions, because they are isobaric. Here, we compare two orthogonal approaches for the accurate differentiation of five isomeric n-NMA MeC impurities in a NMA PS ASO sample: (1) desulfurization to enhance chromatographic separation of the individual components of the composite n-NMA MeC impurity, thus enabling straightforward quantitation via LCMS, and (2) direct fragmentation of n-NMA MeC impurities to calculate the content of individual standards using their distinctive MS/MS fragments. Our strategies established the feasibility of resolving up to five isomeric n-1 impurities and allowed us to mitigate the risk of their formation during synthesis. The study results revealed that low coupling efficiency occurred at the NMA MeC nucleotides toward the 5' end of the sequence, which provided valuable insights into the sequence-specific challenges associated with synthesis efficiency and guided us to implement more effective n-1 control measures during the oligonucleotide synthetic process.


  • Open Access

    Strategies for the evaluation and characterization of higher-order structures, supramolecular higher-order structures, and aggregates in oligonucleotide therapeutics

    by Laure-Elie Carloni, George Bou-Assaf, Arani Chanda, Lingwen Cui, Ahmed Elmekawy, Maryam Farzan, Leo Joyce, Ranajoy Majumdar, Zahid Nazir, Ulrike Rieder, et al.


  • Open Access

    Increasing the Throughput of CE-SDS Experiments for the Determination of Purity in Biotherapeutic Products – A Bridging Case Study

    by George Bou-Assaf, Dana Tribby, Marcia Santos

    Capillary electrophoresis sodium dodecyl sulfate (CE-SDS) is a workhorse method for the characterization of purity and impurities attributes of biotherapeutic products. In this study, we compared the performance, throughput, and precision of two instruments manufactured by Sciex: the newly developed BioPhase 8800 and the classical PA800+. Four different monoclonal antibodies, anonymized as mAb A-D, were analyzed under reducing and non-reducing conditions and with manual and automated sample preparation on both instruments. In addition, a design of experiment (DoE) study was carried out to fully exploit the high throughput capabilities of the BioPhase 8800. Results demonstrate that data generated on the BioPhase 8800 were highly comparable to those obtained on the PA800+ instrument and that high precision was easily achievable with both manual and automated sample preparation. Moreover, because the throughput of the BioPhase 8800 is 8-fold higher than that of the PA800+, screening and DoE studies become a mainstream application of CE-SDS experiments.


  • Assessment of Stereochemical Comparability in Phosphorothioated Oligonucleotides by CD, 31P NMR, and NP1 Digestion Coupled to LC-MS

    by Nicholas R. Larson, Fei Tong, Zifan Li, Yueheng Zhang, Li Xiao, Xuan Zhou, Jonas P. Immel-Brown, George M. Bou-Assaf

    Substitution of a nonbridging oxygen for sulfur on the phosphodiester backbone of an oligonucleotide enhances its pharmacokinetic properties. This substitution creates a new chiral center at the phosphorus atom of the linkage. Oligonucleotides with >10 phosphorothioate linkages are therefore mixtures of thousands to hundreds of thousands of diastereomers. From a chemistry, manufacturing, and control perspective, it is essential to ensure manufacturing consistency and product quality by controlling the factors that influence stereochemistry during synthesis and by implementing the proper analytical tools to analyze the stereochemical composition of phosphorothioated oligonucleotides. Here, we evaluated three orthogonal methods─circular dichroism (CD), 31P-nuclear magnetic resonance (31P NMR), and nuclease P1 (NP1) digestion followed by liquid chromatography coupled to mass spectrometry (LC-MS)─for their sensitivity to detect a change in stereochemical composition and therefore their ability to monitor batch-to-batch stereochemical comparability. Whereas all three methods are able to detect changes in R/S composition, the NP1/LC-MS method demonstrates superior sensitivity compared to the spectroscopic methods (CD and 31P NMR) and allows spatial localization of the changes.


  • Increasing the Resolution of Field-Flow Fractionation with Increasing Crossflow Gradients

    by Nicholas R. Larson, George M. Bou-Assaf

    The resolution of flow field-flow fractionation (flow FFF) depends primarily on the crossflow rate and its change over time. In this work, we demonstrate a method for modulation of the crossflow rate during separation that increases the peak-to-peak resolution of the resulting fractograms. In classical FFF methods, the crossflow rate is either maintained constant or decreased during the separation of the different species. In this work, higher resolution between peaks was achieved by a novel gradient method in which the crossflow is increased briefly during separation to allow stronger retention of the later eluting peaks. We first outline the theoretical basis by which improved separation is achieved. We confirm our hypothesis by quantifying the impact of increasing crossflow on the resolution between a monoclonal antibody monomer and its high-molecular-weight aggregate. We then demonstrate that this method is applicable to two different FFF methods (AF4 and HF5) and various pharmaceutically relevant samples (monoclonal antibodies and adeno-associated viruses). Finally, we hypothesize that increasing the force perpendicular to the laminar flow as described here is broadly applicable to all FFF methods and improves the quality of FFF-based separations.


  • Open Access

    Establishing stereochemical comparability in phosphorothioate oligonucleotides with nuclease P1 digestion coupled with LCMS analysis

    by Zifan Li, Fei Tong, Li Xiao, Nicholas R. Larson, Xuan Zhou, Yueheng Zhang, Jonas P. Immel-Brown, George M. Bou-Assaf

    NP1 digestion coupled with UHPLC-HRMS can provide valuable information on stereochemical comparability between phosphorothioate oligonucleotides by examining digestion fragments.


  • Open Access

    Increasing the resolution of field flow fractionation with increasing crossflow gradients

    by Nicholas Larson, George Bou-Assaf

    The resolution of flow field flow fractionation (flow FFF) depends primarily on the crossflow rate and its change over time. In this work we demonstrate a method for modulation of the crossflow rate during separation increases the peak-to-peak resolution of the resulting fractograms. In classical FFF methods, the crossflow rate is either maintained constant or decreased during separation of the different species. In this work, higher resolution between peaks was achieved by a novel gradient method in which the crossflow is increased briefly during separation to allow stronger retention of the later eluting peaks. We first outline the theoretical basis by which the improved separation is achieved. We confirm our hypothesis by quantifying the impact of increasing crossflow on the resolution between a monoclonal antibody monomer and its high molecular weight (HMW) aggregate. We then demonstrate that this method is applicable to two different FFF methods (AF4 and HF5) and various pharmaceutically relevant samples (monoclonal antibodies (mAbs) and adeno-associated viruses (AAV)). Finally, we hypothesize that increasing the force perpendicular to laminar flow as described here is broadly applicable to all FFF methods and improve the quality of FFF-based separations.

  • Interlaboratory Comparison of Hydrogen–Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb

    by Jeffrey W. Hudgens, Elyssia S. Gallagher, Ioannis Karageorgos, Kyle W. Anderson, James J. Filliben, Richard Y.-C. Huang, Guodong Chen, George M. Bou-Assaf, Alfonso Espada, Michael J. Chalmers, et al.

    Hydrogen–deuterium exchange mass spectrometry (HDX-MS) is an established, powerful tool for investigating protein–ligand interactions, protein folding, and protein dynamics. However, HDX-MS is still an emergent tool for quality control of biopharmaceuticals and for establishing dynamic similarity between a biosimilar and an innovator therapeutic. Because industry will conduct quality control and similarity measurements over a product lifetime and in multiple locations, an understanding of HDX-MS reproducibility is critical. To determine the reproducibility of continuous-labeling, bottom-up HDX-MS measurements, the present interlaboratory comparison project evaluated deuterium uptake data from the Fab fragment of NISTmAb reference material (PDB: 5K8A) from 15 laboratories. Laboratories reported ∼89 800 centroid measurements for 430 proteolytic peptide sequences of the Fab fragment (∼78 900 centroids), giving ∼100% coverage, and ∼10 900 centroid measurements for 77 peptide sequences of the Fc fragment. Nearly half of peptide sequences are unique to the reporting laboratory, and only two sequences are reported by all laboratories. The majority of the laboratories (87%) exhibited centroid mass laboratory repeatability precisions of ⟨sLab⟩ ≤ (0.15 ± 0.01) Da (1σx̅). All laboratories achieved ⟨sLab⟩ ≤ 0.4 Da. For immersions of protein at THDX = (3.6 to 25) °C and for D2O exchange times of tHDX = (30 s to 4 h) the reproducibility of back-exchange corrected, deuterium uptake measurements for the 15 laboratories is σreproducibility15 Laboratories(tHDX) = (9.0 ± 0.9) % (1σ). A nine laboratory cohort that immersed samples at THDX = 25 °C exhibited reproducibility of σreproducibility25C cohort(tHDX) = (6.5 ± 0.6) % for back-exchange corrected, deuterium uptake measurements.